Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6

被引：0
|
作者：
H. Hadidi
Y. Irshaid
C. Broberg Vågbø
A. Brunsvik
S. Cholerton
K. Zahlsen
J. R. Idle
机构：
[1] Department of Medical Genetics,
[2] Regional Hospital in Trondheim,undefined
[3] Eirik Jarls Gate 10,undefined
[4] N-7006 Trondheim,undefined
[5] Norway e-mail: jeffreyi@medisin.ntnu.no Tel.: +47 73 598879 Fax: +47 73 590560,undefined
[6] Department of Pharmacology,undefined
[7] Faculty of Medicine,undefined
[8] Jordan University of Science and Technology,undefined
[9] Irbid,undefined
[10] Jordan,undefined
[11] Department of Pharmacological Sciences,undefined
[12] Medical School,undefined
[13] Newcastle upon Tyne,undefined
[14] UK,undefined
来源：
European Journal of Clinical Pharmacology | 1998年 / 54卷
关键词：
Key words Coumarin; Metabolism; Risk evaluation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To determine the variability of coumarin 7- and 3-hydroxylation in a human population and to evaluate the evidence for the existence of genetic polymorphism in these pathways. 7-Hydroxylation of coumarin is considered to be a detoxication pathway, whilst 3-hydroxylation, which predominates in rats, leads to hepatotoxicity in the rat. Coumarin metabolic phenotypes could aid in refining the risk evaluation for humans of dietary and environmental exposure to coumarin and for the chronic use of coumarin in high doses as a drug to treat lymphoedema and certain cancers.
引用
收藏
页码：437 / 441
页数：4
相关论文
共 50 条
  • [21] Genetic polymorphism of CYP2U1, a cytochrome P450 involved in fatty acids hydroxylation
    Devos, Aurore
    Cardenas, Christian Lacks Lino
    Glowacki, Francois
    Engels, Anne
    Lo-Guidice, Jean-Marc
    Chevalier, Dany
    Allorge, Delphine
    Broly, Franck
    Cauffiez, Christelle
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2010, 83 (02): : 105 - 110
  • [22] Inhibition of cytochrome P450 2A participating in coumarin 7-hydroxylation in pig liver microsomes
    Liu, Z. -Y.
    Dai, M. -H.
    Tao, Y. -F.
    Chen, D. -M.
    Yuan, Z. -H.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2011, 34 (05) : 424 - 429
  • [23] Inhibitory Potency of 8-Methoxypsoralen on Cytochrome P450 2A6 (CYP2A6) Allelic Variants CYP2A6*15, CYP2A6*16, CYP2A6*21 and CYP2A6*22: Differential Susceptibility Due to Different Sequence Locations of the Mutations
    Tiong, Kai Hung
    Yunus, Nafees Ahemad Mohammed
    Yiap, Beow Chin
    Tan, Eng Lai
    Ismail, Rusli
    Ong, Chin Eng
    PLOS ONE, 2014, 9 (01):
  • [24] A GENETIC-POLYMORPHISM IN COUMARIN 7-HYDROXYLATION - SEQUENCE OF THE HUMAN CYP2A GENES AND IDENTIFICATION OF VARIANT CYP2A6 ALLELES
    FERNANDEZSALGUERO, P
    HOFFMAN, SMG
    CHOLERTON, S
    MOHRENWEISER, H
    RAUNIO, H
    RAUTIO, A
    PELKONEN, O
    HUANG, JD
    EVANS, WE
    IDLE, JR
    GONZALEZ, FJ
    AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (03) : 651 - 660
  • [25] Synthetic Models Related to Methoxalen and Menthofuran-Cytochrome P450 (CYP) 2A6 Interactions. Benzofuran and Coumarin Derivatives as Potent and Selective Inhibitors of CYP2A6
    Yamaguchi, Yuki
    Akimoto, Ichie
    Motegi, Kyoko
    Yoshimura, Teruki
    Wada, Keiji
    Nishizono, Naozumi
    Oda, Kazuaki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2013, 61 (10) : 997 - 1001
  • [26] Role of cytochrome P450 2D6 genetic polymorphism in carvedilol hydroxylation in vitro
    Wang, Zhe
    Wang, Li
    Xu, Ren-ai
    Zhan, Yun-yun
    Huang, Cheng-ke
    Dai, Da-peng
    Cai, Jian-ping
    Hu, Guo-xin
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 1909 - 1916
  • [27] GENETIC POLYMORPHISM IN CYTOCHROME P450 2D6 (CYP2D6): POPULATION DISTRIBUTION OF CYP2D6 ACTIVITY
    Neafsey, Patricia
    Ginsberg, Gary
    Hattis, Dale
    Sonawane, Babasaheb
    JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART B-CRITICAL REVIEWS, 2009, 12 (5-6): : 334 - 361
  • [28] Genetic polymorphisms in the cytochrome P450 2A6 (CYP2A6) gene:: Implications for interindividual differences in nicotine metabolism
    Oscarson, M
    DRUG METABOLISM AND DISPOSITION, 2001, 29 (02) : 91 - 95
  • [29] Cytochrome P450 - CYP2D6 polymorphism in head and neck cancer patients
    Stefanovic, M
    Begonja, A
    Topic, E
    Curcic, I
    Simundic, A
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 : 110 - 111
  • [30] Guinea pig liver cytochrome P450 responsible for 3-hydroxylation of 2,5,2 prime ,5 prime -tetrachlorobiphenyl
    Koga, N.
    Kanamaru, T.
    Kikuichi, N.
    Oishi, N.
    Kato, S.
    Yoshimura, H.
    Bulletin of Environmental Contamination and Toxicology, 1998, 60 (06):
12345